The immediate implant placement through maxgraft^® bonering ensures primary stability of the implant and the ring. The technique reduces treatment time and avoids the reentry to place an implant. This reduces morbidity and increases patient acceptance.

The certified production process at the Cells⁺ Tissuebank Austria (C⁺TBA) ensures highest safety standards. The process involves donor selection, serological testing and a wetchemical purification process to eliminate bacteria, virus, proteins and fungi. The final sterilization by gamma-irradiation guarantees a sterility of the packaging and a 5-year self-life at room temperature.

The purification process maintains the structural features and the interconnected macroporosity of human bone. Furthermore it retains its collagen matrix. maxgraft^® is composed of approx. 70 % mineral and approx. 30 % of human collagen. The lyophilisation maintains the natural structure of the tissue and a residual moisture level of 5 %. Therefore maxgraft^® bonering doesn’t need to be rehydrated.

SEM pictures of maxgraft® at a 100-fold and 5000-fold magnification, showing the macroporous structure and surface of the mineralized collagen matrix

The porous structure of maxgraft^® bonering allows optimal graft revascularization and ensures the supply with vital cells. The properties of maxgraft^® bonering encourage the migration of cells into the surgical site. Therefore a fast bony integration of maxgraft^® bonering and the implant is facilitated.

The cancellous bone structure and the porosity of the maxgraft^® bonering allows fast absorption of blood and the fast suppy of the surgical site with vital cells. The lyophilisation maintains a residual moisture level of 5%. Therefore a rehydration is not necessary.